{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:26:21Z","timestamp":1780626381756,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.adro.2023.101268","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:47:36Z","timestamp":1684414056000},"page":"101268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trimodal Therapy Using an MR\u2013guided Radiation Therapy Partial Bladder Tumor Boost in Muscle Invasive Bladder Cancer"],"prefix":"10.1016","volume":"8","author":[{"given":"Casey","family":"Liveringhouse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Netzley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren C.","family":"Linkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Weygand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammoren","family":"Dohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha","family":"Dookhoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kujtim","family":"Latifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier F.","family":"Torres-Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.S.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosj","family":"Yamoah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Daniel","family":"Grass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2023.101268_bib0001","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.adro.2023.101268_bib0002","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1200\/JCO.2014.57.5548","article-title":"Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: A pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233","volume":"32","author":"Mak","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2023.101268_bib0003","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","article-title":"Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer","volume":"366","author":"James","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.adro.2023.101268_bib0004","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.critrevonc.2014.11.007","article-title":"A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC)","volume":"94","author":"Arcangeli","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.adro.2023.101268_bib0005","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2022.04.017","article-title":"Chemoradiotherapy in muscle-invasive bladder cancer: 10-yr follow-up of the phase 3 randomised controlled BC2001 trial","volume":"82","author":"Hall","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2023.101268_bib0006","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1200\/JCO.2016.69.2327","article-title":"Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic","volume":"35","author":"Kulkarni","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2023.101268_bib0007","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijrobp.2003.10.018","article-title":"Radiotherapy for muscle-invasive carcinoma of the bladder: Results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy","volume":"59","author":"Cowan","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101268_bib0008","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijrobp.2013.06.2044","article-title":"Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: Results of the BC2001 trial (CRUK\/01\/004)","volume":"87","author":"Huddart","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101268_bib0009","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1200\/JCO.2010.28.4950","article-title":"Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma","volume":"28","author":"Hoskin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2023.101268_bib0010","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ijrobp.2015.12.379","article-title":"Prospective study delivering simultaneous integrated high-dose tumor boost (\u226470 Gy) with image guided adaptive radiation therapy for radical treatment of localized muscle-invasive bladder cancer","volume":"94","author":"Hafeez","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101268_bib0011","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/0971-6203.44472","article-title":"Tumor delineation: The weakest link in the search for accuracy in radiotherapy","volume":"33","author":"Njeh","year":"2008","journal-title":"J Med Phys"},{"key":"10.1016\/j.adro.2023.101268_bib0012","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0022-5347(05)67522-2","article-title":"Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy","volume":"163","author":"Paik","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.adro.2023.101268_bib0013","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1148\/radiol.2017171028","article-title":"The diagnostic value of MR imaging in differentiating T staging of bladder cancer: A meta-analysis","volume":"286","author":"Huang","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.adro.2023.101268_bib0014","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/bju.14366","article-title":"Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: Systematic review and meta-analysis","volume":"122","author":"Gandhi","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.adro.2023.101268_bib0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejrad.2017.07.021","article-title":"Diagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: A systematic review and meta-analysis","volume":"95","author":"Woo","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.adro.2023.101268_bib0016","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3109\/0284186X.2015.1062541","article-title":"Comparison of onboard low-field magnetic resonance imaging versus onboard computed tomography for anatomy visualization in radiotherapy","volume":"54","author":"Noel","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.adro.2023.101268_bib0017","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0167-8140(03)00246-9","article-title":"Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer","volume":"69","author":"Muren","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101268_bib0018","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2014.08.019","article-title":"Inter- and intra-fractional bladder motion during radiotherapy for bladder cancer: A comparison of full and empty bladders","volume":"113","author":"Dees-Ribbers","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101268_bib0019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2015.11.003","article-title":"The potential of MRI-guided online adaptive re-optimisation in radiotherapy of urinary bladder cancer","volume":"118","author":"Vestergaard","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101268_bib0020","doi-asserted-by":"crossref","first-page":"S455","DOI":"10.1016\/S0167-8140(19)31284-8","article-title":"PO-0864 normal tissue sparing with diffusion weighted MRI informed tumour boost in bladder radiotherapy","volume":"133","author":"Chan","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101268_bib0021","first-page":"46","article-title":"Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer","volume":"25","author":"Hunt","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101268_bib0022","first-page":"27","article-title":"Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac","volume":"35","author":"Mitchell","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101268_bib0023","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clon.2021.03.023","article-title":"Image-guided adaptive radiotherapy for bladder cancer","volume":"33","author":"Kong","year":"2021","journal-title":"Clin Oncol"},{"key":"10.1016\/j.adro.2023.101268_bib0024","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1470-2045(20)30607-0","article-title":"Hypofractionated radiotherapy in locally advanced bladder cancer: An individual patient data meta-analysis of the BC2001 and BCON trials","volume":"22","author":"Choudhury","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2023.101268_bib0025","article-title":"Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): Radiotherapy planning and delivery guidance","volume":"10","author":"Hafeez","year":"2020","journal-title":"BMJ Open"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109423000970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109423000970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:42:39Z","timestamp":1762530159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109423000970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2452109423000970"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2023.101268","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trimodal Therapy Using an MR\u2013guided Radiation Therapy Partial Bladder Tumor Boost in Muscle Invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2023.101268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101268"}}